Clinically Meaningful Improvements in St George's Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

被引：0
|
作者：
Kraft, M. [1 ]
Corren, J. [2 ]
Ambrose, C. S. [3 ]
Cook, B. [3 ]
Clarke, N. [4 ]
Hunter, G. [5 ]
Molfino, N. [6 ]
Ponnarambil, S. [7 ]
机构：
[1] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[4] AstraZeneca, Patient Centered Sci, Resp & Immunol, Gaithersburg, MD USA
[5] AstraZeneca, Late Stage Dev, Resp & Immunol, BioPharmaceut R&D,Biometr, Cambridge, England
[6] Amgen Inc, Global Dev, Thousand Oaks, CA USA
[7] Astrazeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2360
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
    Carr, Tara
    Bernstein, Jonathan
    Cook, Bill
    Hunter, Gillian
    Ambrose, Chris
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB152 - AB152
  • [2] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study
    Kraft, M.
    Chupp, G. L.
    Reeh, K.
    Lindsley, A. W.
    Cook, B.
    Hunter, G.
    Ambrose, C. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] TEZEPELUMAB PRODUCES CLINICALLY MEANINGFUL RESPONSES ON PATIENT-REPORTED OUTCOME MEASURES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
    Lugogo, Njira
    Ponnarambil, Sandhia
    Ambrose, Christopher
    Cook, William
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Corren, Jonathan
    [J]. CHEST, 2021, 160 (04) : 44A - 47A
  • [4] Characteristics of Asthma Exacerbations That Required Hospitalization in Patients with Severe, Uncontrolled Asthma Receiving Tezepelumab Compared with Placebo: Results from the Phase 3 NAVIGATOR Study
    Ambrose, C. S.
    Cook, B.
    Roseti, S. L.
    Gelhorn, H.
    Cutts, K.
    Lindsley, A. W.
    Colice, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Ambrose, Christopher S.
    Colice, Gene
    Hunter, Gillian
    Cook, Bill
    Molfino, Nestor A.
    Llanos, Jean-Pierre
    Israel, Elliot
    [J]. ADVANCES IN THERAPY, 2023, 40 (11) : 4957 - 4971
  • [6] EFFECT OF TEZEPELUMAB ON LUNG FUNCTION IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 NAVIGATOR STUDY
    Israel, Elliot
    Menzies-Gow, Andrew
    Colice, Gene
    Ambrose, Christopher
    Hunter, Gillian
    Cook, William
    Molfino, Nestor
    Llanos-Ackert, Jean-Pierre
    [J]. CHEST, 2021, 160 (04) : 41A - 43A
  • [7] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [8] Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Hoyte, Flavia
    Martin, Neil
    Kmita, Kamil
    Roseti, Stephanie
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB63 - AB63
  • [9] Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Andrew Menzies-Gow
    Christopher S. Ambrose
    Gene Colice
    Gillian Hunter
    Bill Cook
    Nestor A. Molfino
    Jean-Pierre Llanos
    Elliot Israel
    [J]. Advances in Therapy, 2023, 40 : 4957 - 4971
  • [10] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma With Aspirin-exacerbated Respiratory Disease: Results From the NAVIGATOR Study
    Bernstein, Jonathan
    Laidlaw, Tanya
    Buccheit, Kathleen
    Cahill, Katherine
    Martin, Nicole
    Ponnarambil, Sandhia
    Parikh, Bhavini
    Ambrose, Christopher
    Lindsley, Andrew
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB101 - AB101
12345